10,644
Total Claims
$574K
Drug Cost
1,266
Beneficiaries
$454
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-68%
Cost per patient vs peers
$454 vs $1,411 avg
-22%
Brand preference vs peers
8.3% vs 10.6% avg
Brand vs Generic
92% generic
Brand: 879 claims · $442K
Generic: 9,702 claims · $129K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 142 | $133K |
| Rivaroxaban | 60 | $60K |
| Sitagliptin Phosphate | 25 | $31K |
| Semaglutide | 16 | $22K |
| Budesonide/Formoterol Fumarate | 29 | $18K |
| Fluticasone/Vilanterol | 28 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 11 | $16K |
| Insulin Degludec | 14 | $10K |
| Rosuvastatin Calcium | 911 | $9,472 |
| Mirabegron | 11 | $9,074 |
| Levothyroxine Sodium | 450 | $5,817 |
| Metoprolol Succinate | 320 | $4,691 |
| Losartan Potassium | 378 | $4,664 |
| Atorvastatin Calcium | 398 | $4,616 |
| Levothyroxine Sodium | 39 | $4,412 |
Prescribing Profile
Patient Profile
76
Avg Age
54%
Female
1.26
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data